CITIGROUP INC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$4,149,000
+3166.9%
110,134
+1378.7%
0.00%
Q4 2020$127,000
+2016.7%
7,448
+449.7%
0.00%
Q3 2020$6,000
-75.0%
1,355
-64.9%
0.00%
Q2 2020$24,000
+4.3%
3,865
-62.5%
0.00%
Q1 2020$23,000
-25.8%
10,293
+50.3%
0.00%
Q4 2019$31,000
-77.7%
6,848
-80.8%
0.00%
Q3 2019$139,000
+25.2%
35,750
+94.1%
0.00%
Q2 2019$111,000
-38.3%
18,414
+36.9%
0.00%
Q1 2019$180,000
-86.2%
13,451
-90.4%
0.00%
-100.0%
Q4 2018$1,301,000
+74.6%
139,875
+161.3%
0.00%0.0%
Q3 2018$745,000
+138.0%
53,528
+170.5%
0.00%
Q2 2018$313,000
-13.5%
19,787
-6.0%
0.00%
Q1 2018$362,000
-81.8%
21,053
-76.8%
0.00%
-100.0%
Q4 2017$1,987,000
+89.4%
90,667
+253.7%
0.00%0.0%
Q3 2017$1,049,000
-24.6%
25,632
-44.6%
0.00%0.0%
Q2 2017$1,392,000
+19.3%
46,231
+43.3%
0.00%0.0%
Q1 2017$1,167,000
-77.3%
32,272
-68.6%
0.00%
-80.0%
Q4 2016$5,145,000
+511.0%
102,668
+540.3%
0.01%
+400.0%
Q3 2016$842,000
+108.9%
16,035
+64.4%
0.00%
Q2 2016$403,000
-58.5%
9,752
-59.2%
0.00%
-100.0%
Q1 2016$970,000
+108.6%
23,886
+113.5%
0.00%
Q4 2015$465,000
-22.8%
11,188
-71.4%
0.00%
-100.0%
Q3 2015$602,000
+81.9%
39,106
+193.5%
0.00%
Q2 2015$331,000
-83.9%
13,323
-85.2%
0.00%
-100.0%
Q1 2015$2,058,000
+433.2%
90,059
+530.1%
0.00%
Q4 2014$386,000
+343.7%
14,292
+92.5%
0.00%
Q3 2014$87,000
-42.8%
7,425
-24.2%
0.00%
Q2 2014$152,000
-27.6%
9,794
-8.2%
0.00%
Q1 2014$210,000
+356.5%
10,669
+292.4%
0.00%
Q4 2013$46,0002,7190.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders